To include your compound in the COVID-19 Resource Center, submit it here.

Lercanidipine: Received approvable letter from FDA

Previously reported results from the double-blind COHORT study in 828 patients showed

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE